deltatrials
Completed NA INTERVENTIONAL 2-arm NCT04271735

Pilot Study to Evaluate the Effect of Nicotinamide Riboside on Immune Activation in Psoriasis

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Atherosclerotic Cardiovascular Disease Cardiometabolic Diseases Dyslipidemia Obesity Psoriasis
Interventions Niagen Placebo
Updated 27 times since 2020 Last updated: Dec 4, 2023 Started: Aug 26, 2020 Primary completion: Dec 19, 2022 Completion: Dec 19, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04271735, this NA trial focuses on Atherosclerotic Cardiovascular Disease and Cardiometabolic Diseases and remains completed. Sponsored by National Heart, Lung, and Blood Institute (NHLBI), it has been updated 27 times since 2020, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Mar 2020 – ~Apr 2020 · 31 days · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Jun 2020 · 31 days · monthly snapshot~Jun 2020 – ~Jul 2020 · 30 days · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Sep 2020 · 31 days · monthly snapshot~Sep 2020 – ~Oct 2020 · 30 days · monthly snapshot~Oct 2020 – ~Dec 2020 · 2 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Apr 2021 · 59 days · monthly snapshot~Apr 2021 – ~May 2021 · 30 days · monthly snapshot~May 2021 – ~Nov 2021 · 6 months · monthly snapshot~Nov 2021 – ~Dec 2021 · 30 days · monthly snapshot~Dec 2021 – ~Jan 2022 · 31 days · monthly snapshot~Jan 2022 – ~Apr 2022 · 3 months · monthly snapshot~Apr 2022 – ~May 2022 · 30 days · monthly snapshot~May 2022 – ~Jun 2022 · 31 days · monthly snapshot~Jun 2022 – ~Jul 2022 · 30 days · monthly snapshot~Jul 2022 – ~Sep 2022 · 2 months · monthly snapshot~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshot~Dec 2022 – ~Feb 2023 · 2 months · monthly snapshot~Feb 2023 – ~Apr 2023 · 59 days · monthly snapshot~Apr 2023 – ~Jan 2024 · 9 months · monthly snapshot~Jan 2024 – ~Jul 2024 · 6 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

27 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2024 — Jul 2024 [monthly]

    Completed NA

    Phase: PHASE2 → NA

  4. Apr 2023 — Jan 2024 [monthly]

    Completed PHASE2

    Status: Recruiting → Completed

  5. Feb 2023 — Apr 2023 [monthly]

    Recruiting PHASE2

▶ Show 22 earlier versions

  1. Dec 2022 — Feb 2023 [monthly]

    Recruiting PHASE2

  2. Sep 2022 — Dec 2022 [monthly]

    Recruiting PHASE2

  3. Jul 2022 — Sep 2022 [monthly]

    Recruiting PHASE2

  4. Jun 2022 — Jul 2022 [monthly]

    Recruiting PHASE2

  5. May 2022 — Jun 2022 [monthly]

    Recruiting PHASE2

  6. Apr 2022 — May 2022 [monthly]

    Recruiting PHASE2

  7. Jan 2022 — Apr 2022 [monthly]

    Recruiting PHASE2

  8. Dec 2021 — Jan 2022 [monthly]

    Recruiting PHASE2

  9. Nov 2021 — Dec 2021 [monthly]

    Recruiting PHASE2

  10. May 2021 — Nov 2021 [monthly]

    Recruiting PHASE2

  11. Apr 2021 — May 2021 [monthly]

    Recruiting PHASE2

  12. Feb 2021 — Apr 2021 [monthly]

    Recruiting PHASE2

  13. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE2

  14. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  15. Oct 2020 — Dec 2020 [monthly]

    Recruiting PHASE2

  16. Sep 2020 — Oct 2020 [monthly]

    Recruiting PHASE2

  17. Aug 2020 — Sep 2020 [monthly]

    Recruiting PHASE2

  18. Jul 2020 — Aug 2020 [monthly]

    Recruiting PHASE2

  19. Jun 2020 — Jul 2020 [monthly]

    Recruiting PHASE2

  20. May 2020 — Jun 2020 [monthly]

    Recruiting PHASE2

  21. Apr 2020 — May 2020 [monthly]

    Recruiting PHASE2

  22. Mar 2020 — Apr 2020 [monthly]

    Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Heart, Lung, and Blood Institute (NHLBI)
Data source: National Institutes of Health Clinical Center (CC)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations